Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 23;20(1):394.
doi: 10.1186/s12876-020-01481-y.

Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system: a case report and review of the literature

Affiliations
Review

Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system: a case report and review of the literature

Larissa Brussa Reis et al. BMC Gastroenterol. .

Abstract

Background: Tuberous Sclerosis Complex (TSC) is a complex and heterogeneous genetic disease that has well-established clinical diagnostic criteria. These criteria do not include gastrointestinal tumors.

Case presentation: We report a 45-year-old patient with a clinical and molecular diagnosis of TSC and a family history of cancer, presenting two rare associated findings: gastrointestinal polyposis and pancreatic neuroendocrine tumor. This patient was subjected to a genetic test with 80 cancer predisposing genes. The genetic panel revealed the presence of a large pathogenic deletion in the TSC2 gene, covering exons 2 to 16 and including the initiation codon. No changes were identified in the colorectal cancer and colorectal polyposis genes.

Discussion and conclusions: We describe a case of TSC that presented tumors of the gastro intestinal tract that are commonly unrelated to the disease. The patient described here emphasizes the importance of considering polyposis of the gastrointestinal tract and low grade neuroendocrine tumor as part of the TSC syndromic phenotype.

Keywords: Adenomatous colonic; Case report; Pancreatic neuroendocrine tumor; Rectal polyposis; Tuberous sclerosis complex.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest or financial disclosure.

Figures

Fig. 1
Fig. 1
Histologic and immunohistochemistry analyses of the renal and hepatic lesions identified in the proband. a and b: Kidney biopsy: round cell neoplasia of the kidney (renal angiomyolipoma). a) HE: haematoxylin and eosin stain, b) Melan A: melanoma antigen. c, d, e and f: Liver biopsy (low grade endocrine neoplasia). c) HE: haematoxylin and eosin stain, d) CGA: chromogranin A antigen, e) HE: haematoxylin and eosin stain, f) Sinapto: synaptophysin (HE and IHC, 200x)
Fig. 2
Fig. 2
Tubular adenoma and Fundic gland polyp (HE). Panel a: tubular adenomas. Panel b: fundic gland polyps (HE, 200x)

Similar articles

Cited by

References

    1. Northrup H, Krueger DA, Group ITSCC Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243–254. doi: 10.1016/j.pediatrneurol.2013.08.001. - DOI - PMC - PubMed
    1. Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;2:1–18. doi: 10.1038/nrdp.2016.35. - DOI - PubMed
    1. Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM. Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol. 2018;93(3):323–331. doi: 10.1590/abd1806-4841.20186972. - DOI - PMC - PubMed
    1. Wataya-Kaneda M, Uemura M, Fujita K, Hirata H, Osuga K, Kagitani-Shimono K, et al. Tuberous sclerosis complex: recent advances in manifestations and therapy. Tuberous sclerosis complex Board of Osaka University Hospital. Int J Urol. 2017;24(9):681–691. doi: 10.1111/iju.13390. - DOI - PubMed
    1. Sahin M, Henske EP, Manning BD, Ess KC, et al. Advances and future directions for tuberous sclerosis complex research: recommendations from the 2015 strategic planning conference. Pediatr Neurol. 2016;60:1–12. doi: 10.1016/j.pediatrneurol.2016.03.015. - DOI - PMC - PubMed

Substances